ENGLISH
|
HINDI
APPS
iPhone
|
iPad
|
BlackBerry
|
Android
Nokia
Windows
Network18
Quotes
Quotes
NAVs
News
Messages
People
Notices
Videos
All
FEEDBACK
Facebook
Follow @moneycontrolcom on Twitter
CNBC TV 18
moneycontrol
News
Markets
Mutual Funds
IPO
Commodities
Wealth
Portfolio
Messages
My TV
Tax
Fixed Income
Property
SME
CNBC-TV18
Home
Business
General News
Market Trends
Stocks
Fund News
Personal Finance
Corporate Strategy
Lifestyle
Politics
Legal
Master Your Money
Share
>
Share
Tweet
Share on Tumblr
Nimish Mehta
News »
latest
by relevance
Cipla a good pick at current levels
Apr 09, 2007 at 16:31
Nimish Mehta of Edelweiss Securities is of the view that Cipla can be a good pick at this point of time.
See moderate to good quarter for pharma: Nimish Mehta
Apr 09, 2007 at 16:04
Earnings season is just round the corner and this week we discuss brokerage estimates for each sectors. Today, we take a look at the pharma sector, and to discuss that we are joined by Nimish Mehta of Edelweiss Securities.
Opting out of Merck race positive for Ranbaxy: Edelweiss
Mar 20, 2007 at 17:18
Ranbaxy is out of the race for Mercks generic business. Nimish Mehta of Edelweiss comments on it.
Opting out of Merck race positive for Ranbaxy: Edelweiss
Mar 20, 2007 at 15:49
Ranbaxy is out of the race for Mercks generic business. Nimish Mehta of Edelweiss comments on it.
Greenply Industries has resistance at Rs 104
Dec 05, 2006 at 14:41
Nimish Mehta of Kantilal chhaganlal is of the view that Greenply Industries has resistance at Rs 104.
Avoid sugar stocks
Dec 05, 2006 at 14:40
Nimish Mehta of Kantilal chhaganlal suggests ignoring sugar stocks. The long term trend looks weak.
See moderate to good quarter for pharma: Nimish Mehta
Apr 09, 2007 at 16:04
Earnings season is just round the corner and this week we discuss brokerage estimates for each sectors. Today, we take a look at the pharma sector, and to discuss that we are joined by Nimish Mehta of Edelweiss Securities.
Cipla a good pick at current levels
Apr 09, 2007 at 16:31
Nimish Mehta of Edelweiss Securities is of the view that Cipla can be a good pick at this point of time.
Opting out of Merck race positive for Ranbaxy: Edelweiss
Mar 20, 2007 at 17:18
Ranbaxy is out of the race for Mercks generic business. Nimish Mehta of Edelweiss comments on it.
Opting out of Merck race positive for Ranbaxy: Edelweiss
Mar 20, 2007 at 15:49
Ranbaxy is out of the race for Mercks generic business. Nimish Mehta of Edelweiss comments on it.
Avoid sugar stocks
Dec 05, 2006 at 14:40
Nimish Mehta of Kantilal chhaganlal suggests ignoring sugar stocks. The long term trend looks weak.
Greenply Industries has resistance at Rs 104
Dec 05, 2006 at 14:41
Nimish Mehta of Kantilal chhaganlal is of the view that Greenply Industries has resistance at Rs 104.
Videos »
See moderate to good quarter for pharma: Nimish Mehta
Cipla a good pick at current levels
Opting out of Merck race positive for Ranbaxy: Edelweiss
Opting out of Merck race positive for Ranbaxy: Edelweiss
more »
Photos »
/
Follow moneycontrol.com
Facebook
Twitter
Google Plus
RSS
Wap SMS
SMS
Alert
iPad
iPhone
Blackberry
OVI
Android
Window
